Work

Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.9046

Authors: Andreas Nicholas Saltos, Tawee Tanvetyanon, Charles C. Williams, Eric B. Haura, Ben C. Creelan, Scott Joseph Antonia, Nishan Tchekmedyian, Kristen Goas, Trevor Mamplata, Ram Thapa, Dung-Tsa Chen, Amer A. Beg, Jhanelle Elaine Gray

Institution: Moffitt Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891839100

Cites:

Cited by: 8

Related to: 10